References
- M. Efentakis and A. Koutlis, Release of furosemide from multiple-unit and single- unit preparations containing different viscosity grades of sodium alginate, Pharm. Dev. Tech.6 (2001) 91--98; DOI: 10.1081/PDT-100000048.
- S. Benita, Survey of Microencapsulation Processes, in Microencapsulation: Methods and Industrial Applications, Marcel Dekker, New York 1996, pp. 1--20.
- I. El-Gibaly and S. K. Abdel-Ghaffer, Effect of hexacosanol on the characteristics of novel sustained-release allupurinol solid lipospheres: factorial design application and product evaluation, Int. J. Pharm.294 (2005) 33--51; DOI: 10.1016/j.ijpharm.2004.12.027.
- J. Varrshosaz and M. Keihanfar, Development and evaluation of sustained-release propranolol wax microspheres, J. Microencaps.18 (2001) 277--284; DOI: 10.1080/02652040010018074.
- R. K. Verma and S. Garg, Development and evaluation of osmotically controlled oral drug delivery system of glipizide, Eur. J. Pharm. Biopharm.57 (2004) 513--525; DOI: 10.1016/j.ejpb.2004.02.003.
- S. Jamzad and R. Fassihi, Development of controlled release low dose class II drug-glipizide, Int. J. Pharm.312 (2006) 24--32; DOI: 10.1016/j.ijpharm.2005.12.037.
- Martindale, The Complete Drug Reference (Ed. S. C. Sweetman), 34th ed., Pharmaceutical Press, London 2005, pp. 324--348.
- J. K. Patel, R. P. Patel, A. F. Amin and M. M. Patel, Formulation and evaluation of glipizide microspheres, AAPS Pharm. Sci. Tech.6 (2005) E49-E55; DOI: 10.1208/pt 060110.
- K. P. R. Chowdary and Y. S. Rao, Design and in vitro and in vivo evaluation of mucoadesive microcapsules of glipizide for oral controlled release, AAPS Pharm. Sci. Tech.4 (2003) 1--6; DOI: 10.1208/pt 0040339.
- G. A. Lewis, D. Mathieu and R. Phan Tan Lui, Response Surface Methodology, in Pharmaceutical Experimental Design, Marcel Dekker, New York 1999, pp. 185--246.
- P. J. Sinko, Micromeritics in Martin's Physical Pharmacy and Pharmaceutical Sciences (Ed. P. J. Sinko), 5th ed., Williams & Wilkins, Philadelphia 2006, pp. 533--560.
- USP XXVII, NF XXII, United States Pharmacopeial Convention, Rockville 2004.
- T. Higuchi, Mechanisms of sustained action medications: theoretical analysis of rate of release of solid drugs dispersed in solid matrices, J. Pharm. Sci.52 (1963) 1145--1149.
- R. W. Korsmeyer, R. Gurny, E. Doelker, P. Buri and N. A. Peppas, Mechanisms of solute release from porous hydrophilic polymers, Int. J. Pharm.15 (1983) 25--35.
- E. Karasulu, H. Y. Karasuslu, G. Ertan, L. Kirilmaz and T. Guneri, Extended release lipophilic indomethacin microspheres: formulation factors and mathematical equations fitted drug release rates, Eur. J. Pharm. Sci.19 (2003) 99--104; DOI: 10.1016/S0928-0987(03)00048-4.
- C. Narendra, M. S. Srinath and B. Prakash Rao, Development of three layered buccal compact containing metoprolol tartarate by statistical optimization technique, Int. J. Pharm.304 (2005) 102--114; DOI: 10.1016/j.ijpharm.2005.07.021.
- S. Jamzad and R. Fassihi, Role of surfactant and pH on dissolution properties of fenofibrate and glipizide — A technical note, AAPS Pharm. Sci. Tech.7 (2006) E1--E6; DOI: 10.1208/pt 070233.
- V. H. K. Li, V. H. L. Lee and J. R. Robinson, Influence of Drug Properties and Routes of Drug Administration on the Design of Sustained and Controlled Release Systems, in Controlled Drug Delivery (Eds. J. R. Robinson and V. H. L. Lee), 2nd ed., Marcel Dekker, New York 1987, pp. 3--94.
- N. Mani and H. W. Jun, Microencapsulation of a hydrophilic drug into a hydrophobic matrix using a salting-out procedure. I: Development and optimization of the process using factorial design, J. Microencapsul.21 (2004) 125--135; DOI: 10.1080/02652040310001619776.
- C. M. Adeyeye and J. C. Price, Development and evaluation of sustained-release ibuprofen-wax microspheres. II. In vitro dissolution studies, Pharm. Res.11 (1994) 575--579; DOI: 10.1023/A: 1018931002991.
- C. M. Adeyeye and J. C. Price, Development and evaluation of sustained-release ibuprofen-wax microspheres. I. Effect of formulation variables on physical characteristics, Pharm. Res.8 (1991) 1377--1383; DOI: 10.1023/A: 1015845022112.
- C. R. Kahn and Y. Shechter, Oral Hypoglycemic Agents and the Pharmacology of the Endocrine Pancreas, in Goodman and Gilman's The Pharmacological Basis of Therapeutics (Eds. W. R. Theodare, S. N Alan, P. Taylor and A. G. Gilman), 8th ed., McGraw-Hill, New York 1991, pp. 1461--1495.